Danielle Ayala is the Product Manager at Aspire, where she has been actively involved in the technology transfer of the Autologous Cellular Therapy, ACP-01, process and the regulatory aspects required to bring it to phase II clinical trial.
Ms. Ayala’s previous biotech experience includes cellular manufacture, process development, quality control, document control and regulatory compliance. Her previous industry experience spans several analytical, molecular and quantitative biology methods. Ms. Ayala received her BSc. in Biology from Warner University and her MSc in Forensic Science (Criminalistics) from the University of New Haven.